Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York, New York 10010


This clinical trial will compare 10 week treatment with acamprosate (2 gr/day) versus placebo, combined with weekly abstinence oriented individual counseling, in methamphetamine dependent patients, 72 subjects will be enrolled, with an interim analysis scheduled after 36 enrolled. Primary outcome is methamphetamine absitience over the 10 week treatment period, and the last 2 weeks of treatment. Abstinence is defined on a weekly basis as no urine positive of methamphetamine (or amphetamine) and self-report of not use for the 7 day period. Secondary measures include treatment retention, drug craving, mood, and safety.


Inclusion Criteria: - Methamphetamine dependence - Treatment seeking - Urine sample (+) for methamphetamine Exclusion Criteria: - Pregnancy - Dependence on other drugs (except nicotine) - DSM-IV axis I disorder unrelated to drug abuse - Serious medical condition in clinicians opinion. - AIDs - Untreated syphilis - Allergy to acamprosate - Methadone, or other ORP, maintenance



Primary Contact:

Principal Investigator
Malcolm Reid, PhD
New York University School of Medicine

Backup Contact:


Location Contact:

New York, New York 10010
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.